| MEIRAGTX HLDGSDL-,0000388 |
| China |
| Gesundheit |
| KYG596651029 / A2JGHF |
| 328 (Frankfurt) / MGTX (NASDAQ) |
| FRA:328, ETR:328, 328:GR, NASDAQ:MGTX |
| - |
| https://meiragtx.com/ |
|
MeiraGTx Holdings plc is a clinical-stage gene the..
>Volltext.. |
| 590.05 Mio. EUR |
| 652.52 Mio. EUR |
| 23.37 Mio. EUR |
| -129.08 Mio. EUR |
| -143.79 Mio. EUR |
| -1.8 EUR |
| 75.06 Mio. EUR |
| 12.65 Mio. EUR |
| -99.1 Mio. EUR |
| 0.1 |
| 86.76% |
| -81.52% |
| - |
| - |
| - |
| - |
| MEIRAGTX |
| 17.12.25 |
|